A cross-sectional pilot study examining the role of circulating immune cells in the presence of type 1 and type 2 diabetes

A pilot study examining the association of white blood cell morphology and O-GlcNAcylation with the presence of established type 1 and type 2 diabetes

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ANZCTR

Registry ID

ACTRN12618001846213

Acronym

BIT (Blood inflammation trial)

Enrollment

Registered

2018-11-14

Start date

2018-11-26

Completion date

Unknown

Last updated

2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

We are aiming to assess the potential differences in immune cell proportions between healthy and diabetic individuals. We hope to identify these differences in order to decipher the gap in knowledge regarding the immune system, diabetes and heart failure.

Interventions

All elective patients (non-diabetic/diabetic) will be invited on the day of their routine visit to participate in the present study. If the patient agrees to participate, a single 10ml blood sample will be collected for subsequent analysis. Blood collection will require no more than 10 minutes of the participant's time.

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Healthy volunteers

Yes

Inclusion criteria

Sex: All Age: 18 - 65 yrs Inclusion criteria; Non-diabetic: any healthy, non-diabetic (normoglycemic) individual Diabetic: Any patients with clinically diagnosed type-1 or type-2 diabetes Informed consent: participant must be able to give personal informed consent Participation in the study: participant must be able to co-operate sufficiently to allow the proposed study to progress. Concomitant medications: no restriction is made in the use of concomitant medications, which will be left to the treating specialist

Exclusion criteria

Nil known

Outcome results